GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Level Bio AB (XSAT:LEVBIO) » Definitions » Price-to-Owner-Earnings

Level Bio AB (XSAT:LEVBIO) Price-to-Owner-Earnings : (As of Jun. 07, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Level Bio AB Price-to-Owner-Earnings?

As of today (2024-06-07), Level Bio AB's share price is kr0.288. Level Bio AB does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Level Bio AB's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Level Bio AB was 239.17. The lowest was 22.84. And the median was 72.56.


XSAT:LEVBIO's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 24.845
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-07), Level Bio AB's share price is kr0.288. Level Bio AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.19. Therefore, Level Bio AB's PE Ratio for today is At Loss.

As of today (2024-06-07), Level Bio AB's share price is kr0.288. Level Bio AB's EPS without NRI for the trailing twelve months (TTM) ended in was kr-0.19. Therefore, Level Bio AB's PE Ratio without NRI for today is At Loss.

During the past 13 years, Level Bio AB's highest PE Ratio without NRI was 566.67. The lowest was 0.00. And the median was 63.69.


Level Bio AB Price-to-Owner-Earnings Historical Data

The historical data trend for Level Bio AB's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Bio AB Price-to-Owner-Earnings Chart

Level Bio AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 70.56 214.17 25.03 -

Level Bio AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Level Bio AB's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Level Bio AB's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Level Bio AB's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Level Bio AB's Price-to-Owner-Earnings falls into.



Level Bio AB Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Level Bio AB's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.288/-0.12
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Level Bio AB  (XSAT:LEVBIO) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Level Bio AB Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Level Bio AB's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Level Bio AB (XSAT:LEVBIO) Business Description

Traded in Other Exchanges
Address
Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
AlphaHelix Molecular Diagnostics AB develops, manufactures, and markets products for DNA-identification and quantitation in molecular diagnostics and life science research. Its product inlcude Rob, BugScreener MRSA, and aAmp. The company applications inlcude Diagnostics, PCR and Liquid handling.

Level Bio AB (XSAT:LEVBIO) Headlines

No Headlines